Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic
Document type Journal Article, Review
PubMed
35889002
PubMed Central
PMC9322045
DOI
10.3390/microorganisms10071283
PII: microorganisms10071283
Knihovny.cz E-resources
- Keywords
- Europe, Western Europe, incidence, recommendations, surveillance, tick-borne encephalitis (TBEV), vaccination, vaccine, vaccine coverage,
- Publication type
- Journal Article MeSH
- Review MeSH
There has been an increase in reported TBE cases in Europe since 2015, reaching a peak in some countries in 2020, highlighting the need for better management of TBE risk in Europe. TBE surveillance is currently limited, in part, due to varying diagnostic guidelines, access to testing, and awareness of TBE. Consequently, TBE prevalence is underestimated and vaccination recommendations inadequate. TBE vaccine uptake is unsatisfactory in many TBE-endemic European countries. This review summarizes the findings of a scientific workshop of experts to improve TBE surveillance and vaccine uptake in Europe. Strategies to improve TBE surveillance and vaccine uptake should focus on: aligning diagnostic criteria and testing across Europe; expanding current vaccine recommendations and reducing their complexity; and increasing public education of the potential risks posed by TBEV infection.
Center for Public Health Medical University of Vienna 1090 Vienna Austria
Department for Infectious Diseases University of Zagreb School of Medicine 10000 Zagreb Croatia
Department of Epidemiology Danylo Halytsky Lviv National Medical University 79010 Lviv Ukraine
Department of Veterinary Biosciences University of Helsinki 00014 Helsinki Finland
Department of Virology Faculty of Medicine University of Helsinki 00014 Helsinki Finland
Faculty of Medicine Carol Davila University of Medicine and Pharmacy 020022 Bucharest Romania
Medical and Scientific Affairs Pfizer Vaccines 1210 Vienna Austria
Medical and Scientific Affairs Pfizer Vaccines 19138 Stockholm Sweden
National Reference Laboratory for TBEV Bundeswehr Institute of Microbiology 80937 Munich Germany
University Hospital for Infectious Diseases Dr Fran Mihaljević Mirogojska 8 10000 Zagreb Croatia
Virology and Immunology HUSLAB Helsinki University Hospital 00260 Helsinki Finland
See more in PubMed
Kerlik J., Avdičová M., Štefkovičová M., Tarkovská V., Pántiková Valachová M., Molčányi T., Mezencev R. Slovakia reports highest occurrence of alimentary tick-borne encephalitis in Europe: Analysis of tick-borne encephalitis outbreaks in Slovakia during 2007–2016. Travel Med. Infect. Dis. 2018;26:37–42. doi: 10.1016/j.tmaid.2018.07.001. PubMed DOI
Chitimia-Dobler L., Mackenstedt U., Kahl O. Chapter 3: Transmission/natural cycle. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 47–63.
Erber W., Schmitt H.J. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study. Ticks Tick Borne Dis. 2018;9:768–777. doi: 10.1016/j.ttbdis.2018.02.007. PubMed DOI
Saydam F.N., Erdem H., Ankarali H., El-Arab Ramadan M.E., El-Sayed N.M., Civljak R., Pshenichnaya N., Moroti R.V., Mahmuodabad F.M., Maduka A.V., et al. Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia. Travel Med. Infect. Dis. 2021;44:102174. doi: 10.1016/j.tmaid.2021.102174. PubMed DOI
European Centre for Disease Prevention and Control . ECDC. Annual Epidemiological Report for 2015. ECDC; Stockholm, Sweden: 2018. Tick-borne encephalitis.
Růžek D., Yoshii K., Bloom M.E., Gould E.A. Chapter 2a: Virology. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 16–31.
Dobler G., Tkachev S. Chapter 11: General epidemiology of TBE. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 141–153.
Bojkiewicz E., Toczyłowski K., Sulik A. Tick-borne encephalitis—A review of current epidemiology, clinical symptoms, management and prevention. Prz. Epidemiol. 2020;74:316–325. doi: 10.32394/pe.74.24. PubMed DOI
Bogovič P., Stupica D., Rojko T., Lotrič-Furlan S., Avšič-Županc T., Kastrin A., Lusa L., Strle F. The long-term outcome of tick-borne encephalitis in Central Europe. Ticks Tick Borne Dis. 2018;9:369–378. doi: 10.1016/j.ttbdis.2017.12.001. PubMed DOI
Erber W., Schmitt H.J., Vuković-Janković T. Chapter 12a: TBE-epidemiology by country—An overview. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 154–170.
Daniel M., Danielová V., Kříž B., Růžek D., Fialová A., Malý M., Materna J., Pejčoch M., Erhart J. The occurrence of Ixodes ricinus ticks and important tick-borne pathogens in areas with high tick-borne encephalitis prevalence in different altitudinal levels of the Czech Republic Part I. Ixodes ricinus ticks and tick-borne encephalitis virus. Epidemiol. Mikrobiol. Imunol. 2016;65:118–128. PubMed
Heinz F.X., Stiasny K., Holzmann H., Kundi M., Sixl W., Wenk M., Kainz W., Essl A., Kunz C. Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance. Eurosurveillance. 2015;20:21077. doi: 10.2807/1560-7917.ES2015.20.13.21077. PubMed DOI
De Pelsmaeker N., Korslund L., Steifetten O. High-elevational occurrence of two tick species, Ixodes ricinus and I. trianguliceps, at their northern distribution range. Parasites Vectors. 2021;14:161. doi: 10.1186/s13071-021-04604-w. PubMed DOI PMC
Surveillance Systems Overview for 2019. [(accessed on 28 April 2022)]. Available online: https://www.ecdc.europa.eu/en/publications-data/surveillance-systems-overview-2019.
Hellenbrand W., Kreusch T., Böhmer M.M., Wagner-Wiening C., Dobler G., Wichmann O., Altmann D. Epidemiology of tick-borne encephalitis (TBE) in Germany, 2001–2018. Pathogens. 2019;8:42. doi: 10.3390/pathogens8020042. PubMed DOI PMC
Banović P., Obregón D., Mijatović D., Simin V., Stankov S., Budakov-Obradović Z., Bujandrić N., Grujić J., Sević S., Turkulov V., et al. Tick-borne encephalitis virus seropositivity among tick infested individuals in Serbia. Pathogens. 2021;10:301. doi: 10.3390/pathogens10030301. PubMed DOI PMC
Stefanoff P., Zielicka-Hardy A., Hlebowicz M., Konior R., Lipowski D., Szenborn L., Siennicka J., Orlikova H., TBE enhanced surveillance working group New endemic foci of tick-borne encephalitis (TBE) identified in districts where testing for TBE was not available before 2009 in Poland. Parasites Vectors. 2013;6:180. doi: 10.1186/1756-3305-6-180. PubMed DOI PMC
Pöllabauer E.M., Kollaritsch H. Chapter 14: Prevention: Vaccines and immunoglobulins. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 367–384.
Loew-Baselli A., Poellabauer E.M., Pavlova B.G., Fritsch S., Firth C., Petermann R., Barrett P.N., Ehrlich H.J. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: Review of a clinical development programme. Vaccine. 2011;29:7307–7319. doi: 10.1016/j.vaccine.2011.07.089. PubMed DOI
Ehrlich H.J., Pavlova B.G., Fritsch S., Poellabauer E.M., Loew-Baselli A., Obermann-Slupetzky O., Maritsch F., Cil I., Dorner F., Barrett P.N. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: Evaluation of safety and immunogenicity. Vaccine. 2003;22:217–223. doi: 10.1016/S0264-410X(03)00563-2. PubMed DOI
Loew-Baselli A., Konior R., Pavlova B.G., Fritsch S., Poellabauer E., Maritsch F., Harmacek P., Krammer M., Barrett P.N., Ehrlich H.J., et al. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: Results of two large phase 3 clinical studies. Vaccine. 2006;24:5256–5263. doi: 10.1016/j.vaccine.2006.03.061. PubMed DOI
Schöndorf I., Beran J., Cizkova D., Lesna V., Banzhoff A., Zent O. Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule. Vaccine. 2007;25:1470–1475. doi: 10.1016/j.vaccine.2006.10.028. PubMed DOI
Zens K.D., Haile S.R., Schmidt A.J., Altpeter E.S., Fehr J.S., Lang P. Retrospective, matched case-control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006–2020. BMJ Open. 2022;12:e061228. doi: 10.1136/bmjopen-2022-061228. PubMed DOI PMC
Erber W., Khan F., Zavadska D., Freimane Z., Dobler G., Böhmer M.M., Jodar L., Schmitt H.J. Effectiveness of TBE vaccination in southern Germany and Latvia. Vaccine. 2022;40:819–825. doi: 10.1016/j.vaccine.2021.12.028. PubMed DOI
Heinz F.X., Holzmann H., Essl A., Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007;25:7559–7567. doi: 10.1016/j.vaccine.2007.08.024. PubMed DOI
Lotrič-Furlan S., Bogovič P., Avšič-Županc T., Jelovšek M., Lusa L., Strle F. Tick-borne encephalitis in patients vaccinated against this disease. J. Intern. Med. 2017;282:142–155. doi: 10.1111/joim.12625. PubMed DOI
Schmitt H.J., Dobler G., Zavadska D., Freimane Z., Fousteris D., Erber W., Jodar L., Palmborg A. TBE vaccination breakthrough cases—Does age matter? Vaccines. 2021;9:932. doi: 10.3390/vaccines9080932. PubMed DOI PMC
Hansson K.E., Rosdahl A., Insulander M., Vene S., Lindquist L., Gredmark-Russ S., Askling H.H. Tick-borne encephalitis vaccine failures: A 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years. Clin. Infect. Dis. 2020;70:245–251. doi: 10.1093/cid/ciz176. PubMed DOI PMC
Kantele A., Rombo L., Vene S., Kundi M., Lindquist L., Erra E.O. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial. Vaccine. 2022;40:1299–1305. doi: 10.1016/j.vaccine.2022.01.022. PubMed DOI
Rosicky B. Notes on the classification of natural foci of tick-borne encephalitis in Central and South-East Europe. J. Hyg. Epidemiol. Microbiol. Immunol. 1959;3:431–443. PubMed
Blaskovic D., Nosek J. The ecological approach to the study of tick-borne encephalitis. Prog. Med. Virol. 1972;14:275–320. PubMed
European Centre for Disease Prevention and Control . Epidemiological Situation of Tick-Borne Encephalitis in the European Union and European Free Trade Association Countries. ECDC; Stockholm, Sweden: 2012.
Croatian Health Statistics Yearbook for 2020 [Croatian] [(accessed on 28 April 2022)]. Available online: https://www.hzjz.hr/hrvatski-zdravstveno-statisticki-ljetopis/hrvatski-zdravstveno-statisticki-ljetopis-za-2020-tablicni-podaci/
Borcić B., Kaić B., Kralj V. Some epidemiological data on TBE and Lyme borreliosis in Croatia. Zentralbl. Bakteriol. 1999;289:540–547. doi: 10.1016/S0934-8840(99)80007-3. PubMed DOI
Mulić R., Petković B., Klismanić Z., Jeroncić I. Tick-borne diseases in the Republic of Croatia. Lijec Vjesn. 2011;133:89–95. PubMed
Vilibic-Cavlek T., Barbic L., Mrzljak A., Brnic D., Klobucar A., Ilic M., Janev-Holcer N., Bogdanic M., Jemersic L., Stevanovic V., et al. Emerging and neglected viruses of zoonotic importance in Croatia. Pathogens. 2021;10:73. doi: 10.3390/pathogens10010073. PubMed DOI PMC
Ilic M., Barbic L., Bogdanic M., Tabain I., Savic V., Kosanovic Licina M.L., Kaic B., Jungic A., Vucelja M., Angelov V., et al. Tick-borne encephalitis outbreak following raw goat milk consumption in a new micro-location, Croatia, June 2019. Ticks Tick Borne Dis. 2020;11:101513. doi: 10.1016/j.ttbdis.2020.101513. PubMed DOI
Zając Z., Bartosik K., Kulisz J., Woźniak A. Incidence of tick-borne encephalitis during the COVID-19 pandemic in selected European countries. J. Clin. Med. 2022;11:803. doi: 10.3390/jcm11030803. PubMed DOI PMC
Official Journal of the European Union Commission Implementing Decision (EU) 2018/945. 2018. [(accessed on 22 June 2022)]. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2018.170.01.0001.01.ENG.
Amato-Gauci A., Zeller H. Tick-borne encephalitis joins the diseases under surveillance in the European Union. Eurosurveillance. 2012;17:20299. doi: 10.2807/ese.17.42.20299-en. PubMed DOI
Case Definition-Tick-Borne Encephalitis (TBE) [(accessed on 28 April 2022)]; Available online: https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&codLeg=64820&parte=2&serie=
Kollaritsch H., Paulke-Korinek M., Holzmann H., Hombach J., Bjorvatn B., Barrett A. Vaccines and vaccination against tick-borne encephalitis. Expert Rev. Vaccines. 2012;11:1103–1119. doi: 10.1586/erv.12.86. PubMed DOI
Zavadska D., Anca I., André F., Bakir M., Chlibek R., Cižman M., Ivaskeviciene I., Mangarov A., Mészner Z., Pokorn M., et al. Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG) Hum. Vaccines Immunother. 2013;9:362–374. doi: 10.4161/hv.22766. PubMed DOI PMC
Ministry of Health of Ukraine ORDER 12/28/2015 NO. 905 [Ukranian] [(accessed on 29 April 2022)]; Available online: https://zakon.rada.gov.ua/laws/show/z0379-16#Text.
Poluga J., Barac A., Katanic N., Rubino S., Milosevic B., Urosevic A., Mitrovic N., Kelic I., Micic J., Stevanovic G. Tick-borne encephalitis in Serbia: A case series. J. Infect. Dev. Ctries. 2019;13:510–515. doi: 10.3855/jidc.11516. PubMed DOI
Borde J., Zajkowska J. Chapter 5: TBE in adults. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 77–91.
Santonja I., Stiasny K., Essl A., Heinz F.X., Kundi M., Holzmann H. Tick-borne encephalitis in vaccinated patients: A retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018. J. Infect. Dis. 2022:jiac075. doi: 10.1093/infdis/jiac075. PubMed DOI
Zavadska D., Odzelevica Z., Karelis G., Liepina L., Litauniece Z.A., Bormane A., Lucenko I., Perevoscikovs J., Bridina L., Veide L., et al. Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016) PLoS ONE. 2018;13:e0204844. doi: 10.1371/journal.pone.0204844. PubMed DOI PMC
Bogovič P., Kastrin A., Lotrič-Furlan S., Ogrinc K., Županc T.A., Korva M., Knap N., Strle F. Clinical and laboratory characteristics and outcome of illness caused by tick-borne encephalitis virus without central nervous system involvement. Emerg. Infect. Dis. 2022;28:291–301. doi: 10.3201/eid2802.211661. PubMed DOI PMC
Steffen R. Tick-borne encephalitis (TBE) in children in Europe: Epidemiology, clinical outcome and comparison of vaccination recommendations. Ticks Tick Borne Dis. 2019;10:100–110. doi: 10.1016/j.ttbdis.2018.08.003. PubMed DOI
Hansson M.E., Orvell C., Engman M.L., Wide K., Lindquist L., Lidefelt K.J., Sundin M. Tick-borne encephalitis in childhood: Rare or missed? Pediatr. Infect. Dis. J. 2011;30:355–357. doi: 10.1097/INF.0b013e3181fe3b5a. PubMed DOI
Dobler G. Chapter 10: Diagnosis. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 133–140.
Popescu C.P., Florescu S.A., Cotar A.I., Badescu D., Ceianu C.S., Zaharia M., Tardei G., Codreanu D., Ceausu E., Ruta S.M. Re-emergence of severe West Nile virus neuroinvasive disease in humans in Romania, 2012 to 2017–implications for travel medicine. Travel Med. Infect. Dis. 2018;22:30–35. doi: 10.1016/j.tmaid.2018.03.001. PubMed DOI
Vasić A., Bjekić J., Veinović G., Mihaljica D., Sukara R., Poluga J., Filipović S.R., Tomanović S. Knowledge, attitudes, and practices on tick-borne encephalitis virus and tick-borne diseases within professionally tick-exposed persons, health care workers, and general population in Serbia: A questionnaire-based study. Int. J. Environ. Res. Public Health. 2022;19:867. doi: 10.3390/ijerph19020867. PubMed DOI PMC
National Institute of Public Health, Romania. National Center for Surveillance and Control of Communicable Diseases Evolution Analysis of Communicable Diseases under Surveillance. Report for 2013 [Romanian] [(accessed on 29 April 2022)]. Available online: https://www.cnscbt.ro/index.php/rapoarte-anuale/547-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2013/file.
National Institute of Public Health, Romania Tick Encephalitis Virus Infection Surveillance System [Romanian] [(accessed on 29 April 2022)]. Available online: https://www.cnscbt.ro/index.php/metodologii/tbe/477-tbe-metodologie/file.
Banović P., Díaz-Sánchez A.A., Đurić S., Sević S., Turkulov V., Lendak D., Mikić S.S., Simin V., Mijatović D., Bogdan I., et al. Unexpected TBEV seropositivity in Serbian patients who recovered from viral meningitis and encephalitis. Pathogens. 2022;11:371. doi: 10.3390/pathogens11030371. PubMed DOI PMC
Ocias L.F., Waldeck M., Hallén I., Nørgaard M., Krogfelt K.A. Transnational exchange of surveillance data reveals previously unrecognized TBEV microfocus. Eur. J. Public Health. 2019;29:631–633. doi: 10.1093/eurpub/ckz059. PubMed DOI PMC
European Centre for Disease Prevention and Control . Data Quality Monitoring and Surveillance System Evaluation: A Handbook of Methods and Applications. ECDC; Stockholm, Sweden: 2014.
National Council of the Slovak Republic . Amendment: 355/2007 Coll. On Protection, Support and Development of Public Health and on Amendments and Supplements to Certain Acts. National Council of the Slovak Republic; Bratislava, Slovakia: 2007.
Tick Activity [Czech] [(accessed on 28 April 2022)]. Available online: https://info.chmi.cz/bio/mapy.php?type=kliste.
Croatian Institute of Public Health Definitions of Common Communicable Diseases Needing Compulsory Reporting. EU Revision 2012 [Croatian] [(accessed on 29 April 2022)]. Available online: https://www.hzjz.hr/hrvatski-zdravstveno-statisticki-ljetopis/hrvatski-zdravstveno-statisticki-ljetopis-za-2020-tablicni-podaci/
Kuchar E., Zajkowska J., Flisiak R., Mastalerz-Migas A., Rosińska M., Szenborn L., Wdówik P., Walusiak-Skorupa J. [Epidemiology, diagnosis, and prevention of tick-borne encephalitis in Poland and selected European countries—A position statement of the Polish group of experts] Med. Pr. 2021;72:193–210. doi: 10.13075/mp.5893.01063. PubMed DOI
Robert Koch Institute Statement of the German Standing Committee on Vaccination at the RKI: Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute—2016/2017. Epidemiol. Bull. 2016;34:301–338.
Decree No. 473/2008 Coll. on the System of Epidemiological Surveillance for Selected Infections, Annex No. 28—Tick-Borne Encephalitis. [(accessed on 20 June 2022)]. Available online: https://www.mpsv.cz/documents/625317/625855/ESCH_10_en.pdf/9d2a257d-eeb6-5846-36fd-dd7a6d640a06.
Swedish Public Health Agency Vaccination Programmes. [(accessed on 29 April 2022)]. Available online: https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/vaccinations/vaccination-programmes/
Stefanoff P., Polkowska A., Giambi C., Levy-Bruhl D., O’Flanagan D., Dematte L., Lopalco P.L., Mereckiene J., Johansen K., D’Ancona F., et al. Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations. Vaccine. 2011;29:1283–1288. doi: 10.1016/j.vaccine.2010.11.077. PubMed DOI
Braks M., van der Giessen J., Kretzschmar M., van Pelt W., Scholte E.J., Reusken C., Zeller H., van Bortel W., Sprong H. Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasites Vectors. 2011;4:192. doi: 10.1186/1756-3305-4-192. PubMed DOI PMC
Finnish Institute for Health and Welfare Infectious Disease Surveillance and Risk Assessment [Finnish] [(accessed on 29 April 2022)]. Available online: https://www.thl.fi/ttr/gen/atlas/html/atlas.html?show=tbe_riskienarviointi.
Statens Serum Institut New Cases of Tick-Borne Encephalitis (TBE) in Tisvilde Hegn in North Zealand and on the Island of Falster. [(accessed on 28 April 2022)]. Available online: https://en.ssi.dk/news/epi-news/2020/no-34-35---2020.
WHO Position Paper on Tick-Borne Encephalitis (TBE) [(accessed on 28 April 2022)]. Available online: https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/tick-borne-encephalitis/who-pp-tbe-2011-summary.pdf?sfvrsn=de01b1fe_2.
Domanovic D., Giesecke J. How to define an area where transmission of arthropod-borne disease is occurring? Eurosurveillance. 2012;17:20171. doi: 10.2807/ese.17.20.20171-en. PubMed DOI
Takken W., Knols B.G.J. Emerging Pests and Vector-Borne Diseases in Europe. Wageningen Academic Publishers; Wageningen, The Netherlands: 2007.
Holding M., Dowall S., Hewson R. Detection of tick-borne encephalitis virus in the UK. Lancet. 2020;395:411. doi: 10.1016/S0140-6736(20)30040-4. PubMed DOI
Biernat B., Cieniuch S., Stanczak J. Detection of TBEV RNA in Ixodes ricinus ticks in north-eastern Poland. Ann. Agric. Environ. Med. 2014;21:689–692. doi: 10.5604/12321966.1129915. PubMed DOI
Pilz A., Erber W., Schmitt H.J. Vaccine uptake in 20 countries in Europe 2020: Focus on tick-borne encephalitis (TBE) [TBC] 2022. submitted . PubMed
Steffen R., Erber W., Schmitt H.J. Can the booster interval for the tick-borne encephalitis (TBE) vaccine ‘FSME-IMMUN’ be prolonged?—A systematic review. Ticks Tick Borne Dis. 2021;12:101779. doi: 10.1016/j.ttbdis.2021.101779. PubMed DOI
Official Gazette of the Republic of Serbia . Rules on Immunization and the Way of Protection with Medicines. Official Gazette of the Republic of Serbia; Beograd, Serbia: 2021.
Kunze M., Erber W., Haditsch M. Chapter 13: TBE as a matter of public health. In: Dobler G., Erber W., Bröker M., Schmitt H.J., editors. The TBE Book. 4th ed. Global Health Press Pte Ltd.; Singapore: 2021. pp. 359–366.
Slunge D. The willingness to pay for vaccination against tick-borne encephalitis and implications for public health policy: Evidence from Sweden. PLoS ONE. 2015;10:e0143875. doi: 10.1371/journal.pone.0143875. PubMed DOI PMC
Act No. 48/1997 Coll., on Public Health Insurance; as Amended by Act No. 371/2021 Coll. [Czech] [(accessed on 29 April 2022)]. Available online: https://www.zakonyprolidi.cz/cs/1997-48?text=48%2F1997.
MacDonald N.E., Sage Working Group on Vaccine Hesitancy Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036. PubMed DOI
Sandhofer M.J., Robak O., Frank H., Kulnig J. Vaccine hesitancy in Austria: A cross-sectional survey. Wien. Klin. Wochenschr. 2017;129:59–64. doi: 10.1007/s00508-016-1062-1. PubMed DOI
Soares P., Rocha J.V., Moniz M., Gama A., Laires P.A., Pedro A.R., Dias S., Leite A., Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9:300. doi: 10.3390/vaccines9030300. PubMed DOI PMC
President’s Opinion Agency for Health Technology Assessment and Tariff System, Poland [Polish] [(accessed on 29 April 2022)]; Available online: https://bipold.aotm.gov.pl/assets/files/oopz/2021/OP-0005-2021.pdf.
Ministry of Health Rules on the Authorization, Organization and Operation of Training Centers Vaccination against COVID-19, from 21 December 2020 [Romanian] [(accessed on 29 April 2022)]. Available online: https://www.cnscbt.ro/index.php/lex/2232-ordin-2171-normele-privind-autorizarea-organizarea-s-i-funct-ionarea-centrelor-de-vaccinare-impotriva-COVID/file.
